ASC/ ASCN - Dealings in securities by Directors ASCENDIS HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2008/005856/06) ISIN: ZAE000185005 Share code: ASC ISIN: ZAE000221891 Share Code: ASCN (“Ascendis” or the “Company”) DEALING IN SECURITIES BY DIRECTORS In accordance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited, shareholders are advised of dealings in securities by the directors of Ascendis as indicated below. Name of Company: Ascendis Health Limited Name of director: Dr. Karsten Wellner, Chief Executive Officer Class of securities: Nil paid letters in terms of the rights offer Nature of transaction: On market sale of remaining nil paid letters (NPL) after receiving funding to follow over 90% of his total rights in the rights offer Nature of interest: Direct beneficial Date of transaction: 29 July 2016 Number of securities: 45,455 Highest Price per NPL: R1.76 Lowest Price per NPL: R1.70 Total value of transactions: R77,826.46 The Ascendis director obtained clearance to trade in terms of section 3.66 of the Listings Requirements. 5 August 2016 Johannesburg Transaction Sponsor Absa Bank Limited (acting through its Corporate and Investment Bank division) Sponsor Investec Bank Limited Date: 05/08/2016 02:13:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.